Fardis Maria 4
4 · IOVANCE BIOTHERAPEUTICS, INC. · Filed Jan 7, 2020
Insider Transaction Report
Form 4
Fardis Maria
DirectorPresident and CEO
Transactions
- Award
Stock Option (right to buy)
2020-01-03+500,000→ 500,000 totalExercise: $25.54Exp: 2030-01-02→ Common stock (500,000 underlying)
Footnotes (1)
- [F1]Provided the Reporting Person is still employed with the Issuer on the following dates, the options are exercisable as follows: (i) options for the purchase of one-third of the 500,000 shares shall vest on the one-year anniversary of January 3, 2020; and (ii) the remaining options shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of January 3, 2020.